Pages that link to "Q37142544"

The following pages link to RNA editing of androgen receptor gene transcripts in prostate cancer cells (Q37142544):

Displaying 20 items.

• A-to-I editing of coding and non-coding RNAs by ADARs (Q26773402) (← links)
• Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells (Q33694557) (← links)
• Molecular diversity through RNA editing: a balancing act. (Q33833030) (← links)
• Identification of novel deregulated RNA metabolism-related genes in non-small cell lung cancer. (Q34372539) (← links)
• The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers (Q36161920) (← links)
• A triad of telomerase, androgen receptor and early growth response 1 in prostate cancer cells. (Q37013269) (← links)
• RNA-DNA sequence differences in Saccharomyces cerevisiae. (Q37383332) (← links)
• ADAR1 overexpression is associated with cervical cancer progression and angiogenesis (Q37597123) (← links)
• Biochemical polymorphism of the growth hormone system proteins and its manifestations in human prostate cells (Q37854759) (← links)
• RNA editing is induced by type I interferon in esophageal squamous cell carcinoma (Q38697151) (← links)
• Discovery Proteomics Identifies a Molecular Link between the Coatomer Protein Complex I and Androgen Receptor-dependent Transcription (Q38760518) (← links)
• Androgen-sensitive microsomal signaling networks coupled to the proliferation and differentiation of human prostate cancer cells (Q42200676) (← links)
• iRNA-AI: identifying the adenosine to inosine editing sites in RNA sequences. (Q42315793) (← links)
• A crossroad of microRNAs and immediate early genes (IEGs) encoding oncogenic transcription factors in breast cancer (Q42501988) (← links)
• An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer (Q47268042) (← links)
• Molecular imaging of prostate cancer. (Q53359744) (← links)
• ADAR1 silencing-induced HUVEC apoptosis is mediated by FGFR2 under hypoxia stress (Q60045752) (← links)
• Radiosensitization by enzalutamide for human prostate cancer is mediated through the DNA damage repair pathway (Q64097035) (← links)
• Metabolomic profiling to evaluate the efficacy of proxalutamide, a novel androgen receptor antagonist, in prostate cancer cells (Q89486246) (← links)
• The aberrant expression of ADAR1 promotes resistance to BET inhibitors in pancreatic cancer by stabilizing c-Myc (Q89737196) (← links)